Protalix BioTherapeutics, Inc. (AMEX: PLX), announced today that the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE